Genzyme Renagel Marketing Message Will Focus On Lipid-Lowering Effect

Phosphate binder may face competition from Shire’s Fosrenol and Amgen’s cinacalcet in the near term. Genzyme views cinacalcet as a "complementary product" rather than a direct competitor.

More from Archive

More from Pink Sheet